No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from the PURE01 study

Subjects

Subjects :

Diseases of the genitourinary system. Urology
RC870-923
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Details

Language :

English

ISSN :

26661683

Volume :

20

Issue :

S168-

Database :

Directory of Open Access Journals

Journal :

European Urology Open Science

Publication Type :

Academic Journal

Accession number :

edsdoj.57e9850a71fd4929943d595a4f8c1fb1

Document Type :

article

Full Text :

https://doi.org/10.1016/S2666-1683(20)35617-2